214 related articles for article (PubMed ID: 16458512)
21. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
22. Glutathione S-transferase of the malarial parasite Plasmodium falciparum: characterization of a potential drug target.
Harwaldt P; Rahlfs S; Becker K
Biol Chem; 2002 May; 383(5):821-30. PubMed ID: 12108547
[TBL] [Abstract][Full Text] [Related]
23. Protein tyrosine kinase activity in human malaria parasite Plasmodium falciparum.
Sharma A
Indian J Exp Biol; 2000 Dec; 38(12):1222-6. PubMed ID: 11411043
[TBL] [Abstract][Full Text] [Related]
24. Intersubunit interactions in Plasmodium falciparum thioredoxin reductase.
Krnajski Z; Gilberger TW; Walter RD; Muller S
J Biol Chem; 2000 Dec; 275(52):40874-8. PubMed ID: 11022050
[TBL] [Abstract][Full Text] [Related]
25. Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action?
Krungkrai J; Scozzafava A; Reungprapavut S; Krungkrai SR; Rattanajak R; Kamchonwongpaisan S; Supuran CT
Bioorg Med Chem; 2005 Jan; 13(2):483-9. PubMed ID: 15598570
[TBL] [Abstract][Full Text] [Related]
26. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
[TBL] [Abstract][Full Text] [Related]
27. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Acta Trop; 2006 Dec; 100(3):185-91. PubMed ID: 17126280
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
[TBL] [Abstract][Full Text] [Related]
29. Generation of oxamic acid libraries: antimalarials and inhibitors of Plasmodium falciparum lactate dehydrogenase.
Choi SR; Beeler AB; Pradhan A; Watkins EB; Rimoldi JM; Tekwani B; Avery MA
J Comb Chem; 2007; 9(2):292-300. PubMed ID: 17316052
[TBL] [Abstract][Full Text] [Related]
30. Microwave-assisted ring opening of epoxides: a general route to the synthesis of 1-aminopropan-2-ols with anti malaria parasite activities.
Robin A; Brown F; Bahamontes-Rosa N; Wu B; Beitz E; Kun JF; Flitsch SL
J Med Chem; 2007 Aug; 50(17):4243-9. PubMed ID: 17665900
[TBL] [Abstract][Full Text] [Related]
31. Determination of antiplasmodial activity and binding affinity of selected natural products towards PfTrxR and PfGR.
Munigunti R; Becker K; Brun R; Calderón AI
Nat Prod Commun; 2013 Aug; 8(8):1135-6. PubMed ID: 24079187
[TBL] [Abstract][Full Text] [Related]
32. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
[TBL] [Abstract][Full Text] [Related]
33. Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure.
Daher W; Biot C; Fandeur T; Jouin H; Pelinski L; Viscogliosi E; Fraisse L; Pradines B; Brocard J; Khalife J; Dive D
Malar J; 2006 Feb; 5():11. PubMed ID: 16464254
[TBL] [Abstract][Full Text] [Related]
34. Development of binding assays to screen ligands for Plasmodium falciparum thioredoxin and glutathione reductases by ultrafiltration and liquid chromatography/mass spectrometry.
Mulabagal V; Calderón AI
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(13-14):987-93. PubMed ID: 20335080
[TBL] [Abstract][Full Text] [Related]
35. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
Wang X; Zhang J; Xu T
Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S
Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Plasmodium falciparum pH regulation by small molecule indole derivatives results in rapid parasite death.
van Schalkwyk DA; Chan XW; Misiano P; Gagliardi S; Farina C; Saliba KJ
Biochem Pharmacol; 2010 May; 79(9):1291-9. PubMed ID: 20067768
[TBL] [Abstract][Full Text] [Related]
38. Benzothiophene carboxamide derivatives as inhibitors of Plasmodium falciparum enoyl-ACP reductase.
Banerjee T; Sharma SK; Kapoor N; Dwivedi V; Surolia N; Surolia A
IUBMB Life; 2011 Dec; 63(12):1101-10. PubMed ID: 22006792
[TBL] [Abstract][Full Text] [Related]
39. Natural product based inhibitors of the thioredoxin-thioredoxin reductase system.
Wipf P; Lynch SM; Birmingham A; Tamayo G; Jiménez A; Campos N; Powis G
Org Biomol Chem; 2004 Jun; 2(11):1651-8. PubMed ID: 15162219
[TBL] [Abstract][Full Text] [Related]
40. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
